Table 1.

Demographic and clinical characteristics of the 117 patients studied

	n (%)
Gender
Male	79 (67.5)
Female	38 (32.5)
Age (years)*	41.1 (9.4)
HCV	50 (42.7)
Years since HIV diagnosis*	10.5 (5.2)
Months on ARV therapy†	20.0 (8.5–39.0)
Current ARV treatment
NNRTI	60 (51.3)
PI	57 (48.7)
Missing doses within the previous week
0	96 (82.1)
1	16 (13.7)
≥ 2	5 (4.2)

Data are expressed as n (%), except where noted. HCV, Hepatitis C virus; ARV, antiretroviral; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.

^*Mean (SD).

^†Median (interquartile range).